Literature DB >> 7068945

Successful treatment of dementia with lithium.

W W Havens, J Cole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7068945     DOI： 10.1097/00004714-198202000-00013

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design.

Authors:  D P Devanand; Jesse G Strickler; Edward D Huey; Elizabeth Crocco; Brent P Forester; Mustafa M Husain; Ipsit V Vahia; Howard Andrews; Melanie M Wall; Gregory H Pelton
Journal:  Contemp Clin Trials       Date:  2018-05-31       Impact factor: 2.226

2.  Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series.

Authors:  Davangere P Devanand; Gregory H Pelton; Kristina D'Antonio; Jesse G Strickler; William C Kreisl; James Noble; Karen Marder; Anne Skomorowsky; Edward D Huey
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

3.  GSK-3 in Neurodegenerative Diseases.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush; Paul A Adlard
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

4.  Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies.

Authors:  Miguel Medina; Juan Jose Garrido; Francisco G Wandosell
Journal:  Front Mol Neurosci       Date:  2011-10-05       Impact factor: 5.639

5.  GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.

Authors:  Hagit Eldar-Finkelman; Ana Martinez
Journal:  Front Mol Neurosci       Date:  2011-10-31       Impact factor: 5.639

6.  Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.

Authors:  D P Devanand; Elizabeth Crocco; Brent P Forester; Mustafa M Husain; Seonjoo Lee; Ipsit V Vahia; Howard Andrews; Laura Simon-Pearson; Nadia Imran; Luminita Luca; Edward D Huey; Deborah A Deliyannides; Gregory H Pelton
Journal:  Am J Geriatr Psychiatry       Date:  2021-05-12       Impact factor: 4.105
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.